- Home
- INBX vs PHK Comparison
INBX vs PHK Comparison
Compare INBX & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INBX | PHK |
|---|---|---|
| Founded | 2010 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 999.7M | 844.1M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | INBX | PHK |
|---|---|---|
| Price | $60.88 | $4.46 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 155.9K | ★ 815.7K |
| Earning Date | 03-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.61% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 550.00 | N/A |
| 52 Week Low | $10.81 | $4.18 |
| 52 Week High | $94.57 | $5.04 |
Technical Indicators
Market Signals| Indicator | INBX | PHK |
|---|---|---|
| Relative Strength Index (RSI) | 37.88 | 32.08 |
| Support Level | $28.54 | N/A |
| Resistance Level | $85.97 | $4.97 |
| Average True Range (ATR) | 4.28 | 0.10 |
| MACD | -0.55 | -0.02 |
| Stochastic Oscillator | 22.30 | 12.50 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. The secondary objective of the company is to seek capital appreciation.